Meet us at Booth #3K236, Vitafoods Europe 2026, Barcelona, Spain, May 5-7, 2026.

Among the various factors that contribute to these processes, amino acids play a crucial role. One such amino acid, L-Hydroxyproline, has garnered attention for its significant impact on wound healing and tissue repair.

In the global amino acid supply chain, documentation is not a formality—it is a technical gatekeeper that determines whether an ingredient can enter regulated pharmaceutical, nutraceutical, and functional formulation markets.

For infants with severe cow’s milk protein allergy (CMPA), multiple food protein intolerance, or extreme gastrointestinal hypersensitivity, infant feeding is not a general nutrition choice—it is a clinical risk management decision.

In pharmaceutical-grade amino acid sourcing, purity is not a marketing claim; it is a regulatory threshold that determines whether a material can enter the supply chain at all. As global pharmaceutical manufacturers tighten impurity controls and traceability requirements, amino acid suppliers are under increasing pressure to deliver consistent molecular purity, batch stability, and GMP-compliant production at scale.